secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-09-15T23:59:59+00:00
Accession:  0001493152-23-032759
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 2.03, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX draws $500K under secured convertible note with Juvenescence; due Feb 14, 2024
--------------------------------------------------------------------------------

- Drew $500,000 of credit available under Amended and Restated Secured Convertible Promissory Note with Juvenescence Limited.
- Repayment date for outstanding principal is February 14, 2024.
- Material terms previously reported in 10-Q and 8-K filings from May, June, and August 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223032759/0001493152-23-032759-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223032759/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-032759

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer